Australia Nasal Drug Delivery Technology Market Size & Outlook
Australia nasal drug delivery technology market, 2018-2030 (US$M)
Related Markets
Australia nasal drug delivery technology market highlights
- The Australia nasal drug delivery technology market generated a revenue of USD 2,250.6 million in 2023 and is expected to reach USD 3,572.9 million by 2030.
- The Australia market is expected to grow at a CAGR of 6.8% from 2024 to 2030.
- In terms of segment, nasal sprays was the largest revenue generating dosage form in 2023.
- Nasal Drops is the most lucrative dosage form segment registering the fastest growth during the forecast period.
Nasal drug delivery technology market data book summary
| Market revenue in 2023 | USD 2,250.6 million |
| Market revenue in 2030 | USD 3,572.9 million |
| Growth rate | 6.8% (CAGR from 2023 to 2030) |
| Largest segment | Nasal sprays |
| Fastest growing segment | Nasal Drops |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Nasal Sprays, Nasal Drops, Nasal Gels, Nasal Powders |
| Key market players worldwide | AstraZeneca PLC, Pfizer Inc, OptiNose Inc, Becton Dickinson & Co, Dr Reddy's Laboratories Ltd ADR, GlaxoSmithKline, B.F. Ascher & Company, Pendopharm, Douglas Pharmaceuticals, ENT Technologies, Naveh Pharma |
Other key industry trends
- In terms of revenue, Australia accounted for 2.9% of the global nasal drug delivery technology market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China nasal drug delivery technology market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 6,740.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nasal Drug Delivery Technology Market Scope
Nasal Drug Delivery Technology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia nasal drug delivery technology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nasal drug delivery technology market will help companies and investors design strategic landscapes.
Nasal sprays was the largest segment with a revenue share of 39.19% in 2023. Horizon Databook has segmented the Australia nasal drug delivery technology market based on nasal sprays, nasal drops, nasal gels, nasal powders covering the revenue growth of each sub-segment from 2018 to 2030.
- Australia Nasal Drug Delivery Technology Dosage Form Outlook (Revenue, USD Million, 2018-2030)
- Nasal Sprays
- Nasal Drops
- Nasal Gels
- Nasal Powders
- Australia Nasal Drug Delivery Technology Container Type Outlook (Revenue, USD Million, 2018-2030)
- Pressurized Containers
- Non-pressurized containers
- Australia Nasal Drug Delivery Technology Application Outlook (Revenue, USD Million, 2018-2030)
- Nasal Congestion
- Rhinitis
- Asthma
- Others
Reasons to subscribe to Australia nasal drug delivery technology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia nasal drug delivery technology market databook
-
Our clientele includes a mix of nasal drug delivery technology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia nasal drug delivery technology market , including forecasts for subscribers. This country databook contains high-level insights into Australia nasal drug delivery technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia nasal drug delivery technology market size, by dosage form, 2018-2030 (US$M)
Australia Nasal Drug Delivery Technology Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
